Fidelity Select Pharmaceuticals Portfolio (FPHAX)
33.29
+0.51
(+1.56%)
USD |
Feb 27 2026
FPHAX Asset Allocations & Exposures
Asset Allocation
As of December 31, 2025.
| Type | % Net |
|---|---|
| Cash | 0.02% |
| Stock | 99.00% |
| Bond | 0.10% |
| Convertible | 0.00% |
| Preferred | 0.59% |
| Other | 0.29% |
Market Capitalization
As of December 31, 2025
| Large | 75.51% |
| Mid | 4.74% |
| Small | 19.75% |
Region Exposure
| Americas | 65.43% |
|---|---|
|
North America
|
65.43% |
| Canada | 0.89% |
| United States | 64.54% |
|
Latin America
|
0.00% |
As of December 31, 2025. Region breakdown data is
calculated by using the long position holdings of the portfolio.
| Greater Europe | 33.10% |
|---|---|
| United Kingdom | 16.00% |
|
Europe Developed
|
17.09% |
| Belgium | 6.49% |
| Denmark | 0.38% |
| Germany | 1.93% |
| Ireland | 1.35% |
| Netherlands | 1.63% |
| Switzerland | 5.31% |
|
Europe Emerging
|
0.00% |
|
Africa And Middle East
|
0.00% |
| Greater Asia | 0.37% |
|---|---|
| Japan | 0.00% |
|
Australasia
|
0.00% |
|
Asia Developed
|
0.37% |
| Singapore | 0.37% |
|
Asia Emerging
|
0.00% |
| Unidentified Region | 1.10% |
|---|
Stock Sector Exposure
| Cyclical |
|
0.00% |
| Materials |
|
0.00% |
| Consumer Discretionary |
|
0.00% |
| Financials |
|
0.00% |
| Real Estate |
|
0.00% |
| Sensitive |
|
0.00% |
| Communication Services |
|
0.00% |
| Energy |
|
0.00% |
| Industrials |
|
0.00% |
| Information Technology |
|
0.00% |
| Defensive |
|
99.26% |
| Consumer Staples |
|
0.00% |
| Health Care |
|
99.26% |
| Utilities |
|
0.00% |
| Not Classified |
|
0.74% |
| Non Classified Equity |
|
0.71% |
| Not Classified - Non Equity |
|
0.04% |
As of December 31, 2025
Stock Style Exposure
| Large Cap Value | -- |
| Large Cap Core | -- |
| Large Cap Growth | -- |
| Mid Cap Value | -- |
| Mid Cap Core | -- |
| Mid Cap Growth | -- |
| Small Cap Value | -- |
| Small Cap Core | -- |
| Small Cap Growth | -- |